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Abstract
Once it was believed that Cdk2 was the master regulator of S phase entry. Gene knockout mouse
studies of cell cycle regulators revealed that Cdk2 is dispensable for S phase initiation and
progression whereby Cdk1 can compensate for the loss of Cdk2. Nevertheless, recent evidence
indicates that Cdk2 is involved in cell cycle independent functions such as DNA damage repair.
Whether these properties are unique to Cdk2 or also being compensated by other Cdks in the
absence of Cdk2 is under extensive investigation. Here we review the emerging new role of Cdk2
in DNA damage repair and also discuss how the loss of Cdk2 impacts the G1/S phase DNA damage
checkpoint.
Introduction
Cyclin dependent kinases (Cdks), a family of serine/thre-
onine kinases, faithfully control the mammalian cell cycle
by binding to cyclins [1]. Under normal circumstances, D-
type cyclins activate Cdk4 and/or Cdk6 and initiate phos-
phorylation of Retinoblastoma protein (Rb) family early
in the G1 phase [2,3]. This leads to the release of E2F tran-
scription factors and results in activation of transcription
of E2F responsive genes required for cell cycle progression
[4,5]. In the late G1 phase, cyclin E activates Cdk2 [2,3]
and completes the phosphorylation of Rb leading to pas-
sage through the restriction point at the boundary of the
G1/S phase, and to S phase initiation. Later Cdk2 plays an
important role in S phase progression by complexing with
cyclin A. Finally Cdk1/cyclin B complexes actively partici-
pate and complete mitosis [6]. Although it was believed
that Cdk2 was essential for S phase entry [7], recent stud-
ies found that Cdk2 is dispensable for S phase initiation
and progression in vivo and Cdk1 can take over Cdk2's
function in its absence [8-10]. Moreover, it was discovered
that Cdk1 alone can drive progression of the mammalian
cell cycle by complexing with all the phase specific cyclins
in the absence of Cdk2, Cdk4, and Cdk6 [11].
Cdk/cyclin complexes, due to their major role in cell cycle
regulation, have become prime targets of inhibition dur-
ing cellular stress, DNA damage, and telomere dysfunc-
tion [12,13]. Two families of Cdk inhibitors regulate the
activities and functions of Cdk/cyclin complexes. The
INK4 family (p16, p15, p18, p19) specifically bind to
Cdk4/Cdk6 and prevent D-type cyclin activity, whereas
the Cip/Kip family (p21, p27, p57) inhibits Cdk2/cyclin
E, Cdk2/cyclin A as well as Cdk1/cyclin B activity
[2,12,14,15]. In response to DNA damage, cell cycle
checkpoints (G1, S, G2/M) are activated and stop cell cycle
progression to allow time for repair thereby preventing
transmission of damaged or incompletely replicated chro-
mosomes [12,16]. Cdk2/cyclin E complexes are inhibited
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to arrest cells at the G1/S checkpoint whereas Cdk1/cyclin
B complexes are inhibited to arrest the cells at G2/M phase
of the cell cycle [12].
Cdk2 in the DNA damage checkpoint and DNA 
repair
The G1 cell cycle checkpoint is primarily responsible for
preventing damaged DNA from being replicated. During
G1/S DNA damage checkpoint arrest, ATM/ATR mediated
activation of p53 activates one of its downstream targets,
p21Cip1/Waf1 [17]. p21 binds to and inhibits Cdk2/cyclin E
complexes thereby arresting cells at the G1/S transition. As
a result, Cdk2 has become the prime target of the G1/S
DNA damage checkpoint and Cdk2 inhibition by p21 is
one essential step in maintaining the G1/S DNA damage
checkpoint [12,17] (Figure 1). Nevertheless, the loss of
Cdk2 presents a different challenge to cells, which in turn
might lead to altered DNA damage response and check-
point activation. An important issue that was ignored with
regard to Cdk2's substitution by Cdk1 is how the G1/S
DNA damage checkpoint functions in the absence of
Cdk2. In this regard the first question that arises, is how
the p53 pathway operates and how is p21 regulated in the
absence of its target Cdk2? If p21 is induced and the cells
arrest at the G1/S checkpoint, which target will be inhib-
ited by p21 in the absence of Cdk2? In this context, the
finding that Cdk1/cyclin E substitutes for Cdk2/cyclin E
presents an interesting twist to the G1/S DNA damage
checkpoint especially due to the fact that Cdk1 is the
prime target for p21 at the G2/M DNA damage checkpoint
[12,18]. In the absence of Cdk2, will Cdk1 be able to reg-
ulate both G1/S and G2/M DNA damage checkpoints? Or
do the cells bypass the G1/S checkpoint in the absence of
Cdk2 and arrest only at the G2/M checkpoint? If Cdk1 is
able to maintain the G1/S checkpoint, will Cdk1 be inhib-
ited by p21 or is it phosphorylated at the inhibitory sites
Thr14/Tyr15 and restricted to the cytoplasm that occurs
under certain circumstances during G2/M DNA damage
checkpoint arrest? As a result it was of interest to reanalyze
the translocation pattern of Cdk1 in response to DNA
damage especially at the G1/S transition in the absence of
Cdk2. Another important question is, if p21 would be
able to arrest cells at the G1/S transition even in the
absence of Cdk2, will this arrest be persistent enough for
the cells to repair their damaged DNA and resume DNA
replication?
In a recent study it was shown that the activation of p53-
p21 pathway is not perturbed in the absence of Cdk2 after
DNA damage. The timing of induction of both p53 and
p21 is similar in the presence or absence of Cdk2. In addi-
tion, cells were arrested promptly at the G1/S checkpoint
in the absence of Cdk2 in response to irradiation induced
DNA damage [19]. This indicates that p21 is able to arrest
cells even in the absence of Cdk2. This observation sug-
gests that p21 can block cell cycle progression by interact-
ing with proteins other than Cdk2. In accordance with
this hypothesis, it was revealed that the translocation of
Cdk1 to the nucleus was not affected by irradiation
induced DNA damage. As a result of premature transloca-
tion of Cdk1 to the nucleus, it co-localized with the
induced p21 and was consequently inhibited by p21 at
the G1/S DNA damage checkpoint. This indicates that in
the absence of Cdk2, Cdk1 is responsible for driving the
cells through the G1/S transition, which in turn is inhib-
ited by p21 in response to DNA damage to maintain the
G1/S checkpoint [19].
It was observed that even in the absence of Cdk2, cells
were arrested for prolonged periods of time similar to wild
type cells in response to irradiation. Moreover, in Cdk2-/-
cells the resumption of DNA replication was delayed after
DNA damage in comparison to Cdk2+/+ cells [19]. Simi-
larly the Cdk2-/- mice displayed increased sensitivity in
response to irradiation and died earlier than wild type
mice. Two possible mechanisms could explain this phe-
nomenon, one is, perhaps loss of Cdk2 renders cells more
sensitive to irradiation and as a result the cells have accu-
mulated more extensive DNA damage in comparison to
wild type cells. Another possibility is that Cdk2 might
possess cell cycle independent functions in DNA repair
Maintenance of the G1/S DNA damage checkpoint in the  presence and absence of Cdk2 Figure 1
Maintenance of the G1/S DNA damage checkpoint in 
the presence and absence of Cdk2. In response to DNA 
damage, activation of p53-p21 pathway is not altered in the 
absence of Cdk2, the primary target of p21 at the G1/S 
checkpoint. In the presence of Cdk2, the induced p21 inhibits 
Cdk2/cyclin E complexes in response to DNA damage. In the 
absence of Cdk2, Cdk1/cyclin E complexes are responsible 
for promotion of the G1/S transition and as a result become 
the target for p21 inhibition in response to DNA damage. 
Nevertheless, Cdk1 is not fully capable to rescue the func-
tions of Cdk2 in DNA damage repair.Cell Division 2009, 4:9 http://www.celldiv.com/content/4/1/9
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and as a result Cdk2-/- cells display delayed resumption of
DNA replication due to impaired DNA repair activity. In
accordance with this hypothesis, more extensive DNA
damage was found in Cdk2-/- cells. In addition, a delayed
and impaired DNA repair activity was detected in Cdk2-/-
cells but it appears that Cdk2-/- cells do not completely fail
to form DNA repair foci (γH2AX, ATM/ATR substrates) at
the sites of damage but rather they exhibited lower num-
bers of foci for prolonged periods of time [19].
In this context it would be interesting to explore the spe-
cific role of Cdk2 in DNA repair. Is Cdk2 part of the DNA
repair complex or does Cdk2 play a more indirect role by
initiating a signal transduction cascade or activating pro-
teins that are involved in DNA repair? In support of this
hypothesis, it was reported that purified Cdk2/cyclin A
can phosphorylate S3291 of BRCA2 in vitro [20] and
when Cdk2 activity is inhibited by Roscovitine, S3291
phosphorylation of BRCA2 is inhibited. This function is
similar to that of Cdk1/cyclin B complexes that are
responsible for phosphorylating S3291 of BRCA2 in mito-
sis, which in turn is necessary for RAD51 binding and
DNA repair [21]. Moreover it was shown that cyclin A1
functions in DSB repair and this repair function is
dependent on Cdk2 activity [22]. It appears that cyclin A1
is essential for the DNA repair function which in turn
depends on the availability of Cdk2. As a result cyclin A1
fails to participate in DNA repair in the absence of Cdk2.
This could be due to the lack of a direct interaction
between cyclin A1 and Cdk1 as evident from the testis of
Cdk2 knockout mice (no compensation of sterility
[9,10]). It has been reported that inhibition of Cdk2 by
Roscovitine leads to blunted activation of Chk1 due to
reduced phosphorylation [22,23]. Chk1 is one of the
downstream targets of the ATM/ATR pathway whose
phosphorylation and activation is one of the necessary
steps in the DNA damage signal transduction cascade
since activated Chk1 in turn activates and promotes sev-
eral DNA repair proteins to the sites of damage [24]. Two
possible mechanisms could explain this phenomenon: 1)
Cdk2 might phosphorylate Chk1 along with ATM/ATR
there by accelerating the phosphorylation and activation
of Chk1. In the absence of Cdk2 the activation process of
Chk1 could be delayed resulting in delayed DNA repair;
2) Alternatively Cdk2 phosphorylates Chk1 at sites other
than the sites which are phosphorylated by ATM/ATR and
phosphorylation of these sites could be essential to com-
plete activation of Chk1.
From the above studies it appears that Cdk2 acts upstream
in the DNA damage pathway and is involved in the activa-
tion of DNA repair proteins (Figure 1). This is quite differ-
ent from the downstream role of inhibited Cdk2 in
arresting the cell cycle at the checkpoint. An interesting
question to answer in this context is how does Cdk2 pro-
mote the activation of DNA repair proteins when it is
present in the inhibited state and its kinase activity is
inhibited by p21? Maybe, Cdk2 can promote DNA repair
activity by direct interactions with other proteins that are
involved in double strand break repair. In the inhibited
state, Cdk2 is already in complex with cyclin E and/or cyc-
lin A and p21, leaving little interaction space on the sur-
face of the Cdk2 molecule. The observation that Cdk2
deficient cells display impaired DNA repair capacity indi-
cates that Cdk1 might be unable to perform the DNA
repair functions of Cdk2 in the absence of Cdk2 although
it is able to trigger the G1/S DNA damage checkpoint.
Another possibility could be that in response to DNA
damage in the presence of Cdk2, p21 mainly targets Cdk2
(and only a few Cdk1 molecules) leaving a sub-pool of
active Cdk1 that plays a role in DNA repair. This sub-pool
of Cdk1 might not be available in the absence of Cdk2
due to higher levels of p21 available to inhibit all of Cdk1.
In support to this hypothesis, it was identified that Cdk1
is essential for DNA double strand break repair in yeast
[25]. Whether Cdk1 plays a similar role in mammalian
cells still needs to be explored.
In contrast to Cdk2's role in the activation of DNA repair
pathways it was also shown that Cdk2 phosphorylates
FOXO1 in response to chemically induced DNA damage
[26]. FOXO transcription factors induce apoptosis by acti-
vating a number of genes including Fas, Bim etc. [27]. In
this study, a connection between Cdk2 and DNA repair
was not detected but they found that FOXO1 phosphor-
ylation and activation by Cdk2 is one of the mechanisms
that triggers apoptosis when there is extensive DNA dam-
age in response to chemical treatment that cannot be
repaired. This further complicates the role of Cdk2 in
DNA damage response. How does Cdk2 distinguish
between moderate and extensive DNA damage? Which
upstream signaling directs Cdk2 to decide whether to acti-
vate Chk1 to repair it or FOXO1 to trigger apoptosis?
Although preliminary information suggests a role of Cdk2
in DNA repair in higher eukaryotic cells, it seems that a
thorough analysis will be necessary in order to define the
specific roles of Cdk2 in DNA repair.
Concluding remarks
From a limited number of studies conducted so far, it
emerges that Cdk2 is necessary for proper DNA repair.
Nevertheless understanding the specific functions of Cdk2
in DNA repair appears to be challenging due to the com-
plexity of the DNA damage signaling pathway. The most
important question to answer is how are Cdk2/cyclin E
and/or Cdk2/cyclin A complexes involved in DNA repair
when they are present in an inhibited state in response to
DNA damage. Although Cdk1 can fully compensate for S
phase functions of Cdk2, it fails to compensate for Cdk2's
DNA repair functions in mammalian cells. Moreover inPublish with BioMed Central    and   every 
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addition to Cdk2's own DNA repair functions, Cdk1's spe-
cific role in mammalian DNA damage repair will also
need to be resolved.
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